Call 408.493.1800 | Fax 408.493.1801 | Toll Free 800.891.9699 (US Only) | Email: [email protected]


A potent mutated BRafV600E inhibitor
Catalog #: B2103
SKU-Size Size Price Qty
B2103-5 5 mg
B2103-25 25 mg
More Sizes Get Quote

Product Details

Alternate Name (S)-methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate; LGX818
Appearance White to off-white solid
CAS # 1269440-17-6
Molecular Formula C₂₂H₂₇ClFN₇O₄S
Molecular Weight 540.01
Purity ≥98% by HPLC
Solubility DMSO
InChi InChI=1S/C22H27ClFN7O4S/c1-12(2)31-11-16(17-6-7-25-21(28-17)26-10-13(3)27-22(32)35-4)20(29-31)15-8-14(23)9-18(19(15)24)30-36(5,33)34/h6-9,11-13,30H,10H2,1-5H3,(H,27,32)(H,25,26,28)/t13-/m0/s1
PubChem CID 50922675
Handling Protect from air and light
Storage Conditions -20°C
Shipping Conditions Gel Pack
USAGE For Research Use Only! Not For Use in Humans.


Encorafenib (LGX818) is a potent mutated BRafV600E inhibitor (IC₅₀ = 0.3 nM) with potential antineoplastic activity. Displays little activity against wild-type B-Raf or a panel of 100 other kinases (IC₅₀s = 900 nM).

Why buy BioVision Products?
Global Presence
Technical Support
BioVision aims to provide our customers innovative tools for accelerating drug discovery and biological research. BioVision offers >8,000 products including the most comprehensive array of assay kits for key targets in Metabolic pathways.
BioVision is committed to providing the highest quality products at a competitive price.
We have a broad network of global distributors who are ready to address your research needs and ensure fast delivery.
Our highly trained Technical Support team provides comprehensive product support and is dedicated to resolving your issues quickly and efficiently.